Detalles de la búsqueda
1.
Minimally Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment: A New Concept.
Ann Surg Oncol
; 31(2): 957-965, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37947974
2.
Radiotherapy statements of the 18th St. Gallen International Breast Cancer Consensus Conference-a German expert perspective.
Strahlenther Onkol
; 200(6): 461-467, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38393398
3.
Characterization of Hormone Receptor and HER2 Status in Breast Cancer Using Mass Spectrometry Imaging.
Int J Mol Sci
; 24(3)2023 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36769215
4.
mdm2 gene amplification is associated with luminal breast cancer progression in humanized PDX mice and a worse outcome of estrogen receptor positive disease.
Int J Cancer
; 150(8): 1357-1372, 2022 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34927257
5.
Diagnosing Pathologic Complete Response in the Breast After Neoadjuvant Systemic Treatment of Breast Cancer Patients by Minimal Invasive Biopsy: Oral Presentation at the San Antonio Breast Cancer Symposium on Friday, December 13, 2019, Program Number GS5-03.
Ann Surg
; 275(3): 576-581, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32657944
6.
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy.
BMC Cancer
; 22(1): 1040, 2022 Oct 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36195836
7.
ASO Visual Abstract: Minimally-Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment-A New Concept.
Ann Surg Oncol
; 31(2): 1033-1034, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38093166
8.
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.
Lancet Oncol
; 19(1): 40-50, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29233559
9.
Outcome after neoadjuvant chemotherapy in estrogen receptor-positive and progesterone receptor-negative breast cancer patients: a pooled analysis of individual patient data from ten prospectively randomized controlled neoadjuvant trials.
Breast Cancer Res Treat
; 167(1): 59-71, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28875243
10.
Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial.
BMC Med
; 16(1): 179, 2018 10 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30301470
11.
Stromal markers AKR1C1 and AKR1C2 are prognostic factors in primary human breast cancer.
Int J Clin Oncol
; 21(3): 548-56, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26573806
12.
Head-to-head comparison of the impact of Aurora A, Aurora B, Repp86, CDK1, CDK2 and Ki67 expression in two of the most relevant gynaecological tumor entities.
Arch Gynecol Obstet
; 294(4): 813-23, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27101368
13.
Clinical implications of first and multiple locoregional breast cancer recurrences.
Arch Gynecol Obstet
; 292(1): 165-73, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25527348
14.
Decision Coaching for Healthy Women With BRCA1/2 Pathogenic VariantsFindings of the Randomized Controlled EDCP-BRCA Trial.
Dtsch Arztebl Int
; (Forthcoming)2024 06 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38629689
15.
Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapy.
NPJ Breast Cancer
; 9(1): 23, 2023 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37029138
16.
Prevalence of Pathogenic Germline Variants in Women with Non-Familial Unilateral Triple-Negative Breast Cancer.
Breast Care (Basel)
; 18(2): 106-112, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37261134
17.
Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti-Human Epidermal Growth Factor Receptor 2 Therapy.
J Clin Oncol
; 41(16): 2988-2997, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36977286
18.
Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial.
Clin Cancer Res
; 29(13): 2456-2465, 2023 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37014668
19.
Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti-Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer.
J Clin Oncol
; 41(16): 2998-3008, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37075276
20.
Treatment of Early Breast Cancer: The 18th St. Gallen International Breast Cancer Consensus Conference against the Background of Current German Treatment Recommendations.
Geburtshilfe Frauenheilkd
; 83(9): 1102-1116, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37706057